>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

  • TXT +6.8%, MTG +5.8%, ISRG +5.5%, CSX +4.6%, UAL +3.6%, MS +2.6%, IBKR +1%

M&A news:

  • TOT +1% (enters into an agreement for the proposed acquisition of Direct Energie to accelerate its ambition in gas and electricity in France and Belgium for EUR 1.4 bln)

Other news:

  • CALA +9.4% (FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for the treatment of patients with metastatic renal cell carcinoma)
  • RIGL +8.3% (confirms FDA approval of TAVALISSE for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia; tgt raised to $8 at BMO Capital Markets)
  • OZM +6.7% (appointed Thomas Sipp, CFA, as Chief Financial Officer)
  • TLGT +6.6% (received approval of its ANDA of Clobetasol Propionate Cream USP, 0.05%; to launch product in Q2)
  • ACRX +4.2% (publication of an analysis of the pharmacokinetic characteristics of sublingually administered tablets containing 15 or 30 mcg of sufentanil in peer-reviewed journal, Anesthesiology)
  • CNAT +4% (publication of results from both in vitro and in vivo studies of its pan-caspase inhibitor, IDN-7314)
  • RIO +3.2% (first quarter production results)
  • VMW +3.1% (Carl Icahn has taken a 'medium sized' position in VMW, according to CNBC)
  • TSLA +2.1% (after Elon Musk letter to employee circulated in late trade; internally targeting 3-4K Model 3 weekly production rate next month and 6K by the end of June), SHPG +1.6% (Swiss agency validates Shire's marketing authorization application for investigational hereditary angioedema treatment lanadelumab)
  • SIG +1.2% (CEO disclosed the purchase of 8980 shares worth ~$350K)
  • JBLU +1.2% (following UAL results)
  • AAL +1.2% (following UAL results)

Analyst comments:

  • EBAY +5.5% (upgraded to Overweight from Underweight at Morgan Stanley)
  • FSLR +3.2% (upgraded to Buy from Neutral at BofA/Merrill)
  • TEX +2.3% (upgraded to Buy from Neutral at Seaport Global Securities)
  • ZAYO +2% (upgraded to Buy from Hold at Deutsche Bank)
  • NCLH +1.3% (upgraded to Buy from Hold at Deutsche Bank)
  • DLTR +1.1% (upgraded to Buy from Hold at Loop Capital)
  • MRVL +1.1% (initiated with a Buy at Longbow)